PDGFRB and systemic sclerosis: First, we show that some subsets of pericytes become myofibroblasts during fibrogenesis in a mouse model of SSc and that the overexpression of SARA, in PDGFR-β+ cells, protects against this transdifferentiation, hence preventing disease progression.